Cargando…
A Case of Metastatic Atypical Neuroendocrine Tumor with ALK Translocation and Diffuse Brain Metastases
A challenge in precision medicine requires identification of actionable driver mutations. Critical to such effort is the deployment of sensitive and well‐validated assays for mutation detection. Although identification of such alterations within the tumor tissue remains the gold standard, many advan...
Autores principales: | Wang, Victoria E., Young, Lauren, Ali, Siraj, Miller, Vincent A., Urisman, Anatoly, Wolfe, John, Bivona, Trever G., Damato, Bertil, Fogh, Shannon, Bergsland, Emily K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AlphaMed Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507651/ https://www.ncbi.nlm.nih.gov/pubmed/28507205 http://dx.doi.org/10.1634/theoncologist.2017-0054 |
Ejemplares similares
-
Detection of an ALK Fusion in Colorectal Carcinoma by Hybrid Capture‐Based Assay of Circulating Tumor DNA
por: Lai, Andrea Z., et al.
Publicado: (2017) -
74325 Vast sex-specific differences in transcriptional landscapes of pancreatic neuroendocrine tumors
por: Ivanov, Nikolay A., et al.
Publicado: (2021) -
Non-Canonical Thinking for Targeting ALK-Fusion Onco-Proteins in Lung Cancer
por: Wu, Wei, et al.
Publicado: (2017) -
Diagnostic Accuracy of FEC-PET/CT, FDG-PET/CT, and Diffusion-Weighted MRI in Detection of Nodal Metastases in Surgically Treated Endometrial and Cervical Carcinoma
por: Rockall, Andrea G., et al.
Publicado: (2021) -
Checkpoint inhibitor is active against large cell neuroendocrine carcinoma with high tumor mutation burden
por: Wang, Victoria E., et al.
Publicado: (2017)